Harbor Investment Advisory’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.9K Buy
+1,426
New +$40.1K ﹤0.01% 801
2023
Q3
– Sell
-1,337
Closed -$66K – 1199
2023
Q2
$66K Buy
1,337
+161
+14% +$7.42K 0.01% 626
2023
Q1
$48.7K Hold
1,176
– – 0.01% 711
2022
Q4
$52.2K Hold
1,176
– – 0.01% 684
2022
Q3
$46K Hold
1,176
– – 0.01% 715
2022
Q2
$48K Buy
1,176
+229
+24% +$10.8K 0.01% 710
2022
Q1
$62K Hold
947
– – 0.01% 683
2021
Q4
$66K Hold
947
– – 0.01% 660
2021
Q3
$66K Buy
947
+90
+11% +$6.93K 0.01% 645
2021
Q2
$68K Buy
857
+211
+33% +$15.3K 0.01% 618
2021
Q1
$42K Buy
646
+239
+59% +$14.7K 0.01% 717
2020
Q4
$23K Buy
+407
New +$17.6K ﹤0.01% 799

Other funds holding ATRC

Harbor Investment Advisory's ATRC Position: Q2 2026 in Review

Harbor Investment Advisory opened a new position in AtriCure (ATRC) in Q2 2026: 1,426 shares worth $39.9K. The stake represents ﹤0.01% of the portfolio and ranks #801 among its holdings. This is a return to the name: Harbor Investment Advisory previously reported a position in ATRC as recently as Q2 2023.

Harbor Investment Advisory first reported a position in ATRC in Q4 2020 and has held it in 12 quarters since. The position peaked at $68K in Q2 2021. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Harbor Investment Advisory held 1,426 shares of AtriCure worth $39.9K as of Q2 2026.
  • AtriCure was a new Harbor Investment Advisory position in Q2 2026.
  • AtriCure made up ﹤0.01% of Harbor Investment Advisory's portfolio in Q2 2026, its #801 holding.
  • Harbor Investment Advisory first reported a position in AtriCure in Q4 2020 and has held it in 12 quarters since.
  • Harbor Investment Advisory's AtriCure position peaked at $68K in Q2 2021.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.